Fennec Pharmaceuticals Inc
Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company. Its product candidate in the clinical stage of development is PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec Pharmaceuticals Inc. in September 2014. Fennec Pharmaceuticals Inc. was incorporated in 1996 and is based in Research Triangle Park, North Carolina. Show More...
-
Website https://www.fennecpharma.com
-
Sector Healthcare
-
Industry Biotechnology
-
Last Quote 8.12 USD
-
Last Updated 30-05-2025
-
External Links Yahoo Finance Morningstar Ratios
-
Interest Coverage
The interest coverage ratio is a debt ratio and profitability ratio used to determine how easily a company can pay interest on its outstanding debt.
Reference: Investopedia -
2010-12 2011-12 2012-12 2013-12 2014-12 2015-12 2016-12 2017-12 2018-12 2019-12 TTM Earnings Per Share USD -1.11 0.57 -0.63 0.17 -0.22 -0.06 -0.22 -0.47 -0.52 -0.64 -0.7 Dividends USD Payout Ratio % * Shares Mil 7.0 8.0 8.0 11.0 10.0 11.0 13.0 15.0 19.0 20.0 20.0 Book Value Per Share * USD -0.56 -0.44 -0.59 -0.42 -0.3 0.09 0.31 0.48 1.15 0.75 0.33 Free Cash Flow Per Share * USD -0.28 -0.3 -0.35 -0.27 -0.14 -0.18 -0.16 -0.2 -0.34 -0.52 Return on Assets % -229.21 82.6 -133.83 89.63 -105.53 -38.87 -111.76 -43.53 -38.51 -68.88 -90.09 Financial Leverage (Average) 3.87 1.86 1.11 1.06 1.08 1.19 1.23 Return on Equity % -113.52 -135.45 -46.47 -41.14 -76.99 -101.02 Return on Invested Capital % -114.04 -135.45 -46.47 -41.14 -76.99 -101.02 Interest Coverage Current Ratio 0.55 0.98 0.32 0.55 1.35 2.16 9.88 17.28 14.02 6.11 5.31 Quick Ratio 0.54 0.97 0.31 0.52 1.31 2.0 9.77 17.19 13.92 6.01 5.19 Debt/Equity